Eurofins Reinforces Market Leadership in Dutch Food and Feed Testing Market with the Acquisition of LZV

  Eurofins Reinforces Market Leadership in Dutch Food and Feed Testing Market
  with the Acquisition of LZV

Business Wire

LUXEMBOURG -- January 30, 2013

Regulatory News :

Eurofins Scientific (EUFI.PA) (Paris:ERF), the global leader in food,
environment and pharmaceutical product testing services, announces the
acquisition of Laboratorium Zeeuws-Vlaanderen (LZV), the reference
agricultural testing laboratory in The Netherlands. LZV also offers testing
services for the food and environmental sectors, and is renowned for
pesticides testing in the local market.

Founded in 1991, LZV employs over 90 staff and generates revenues of over EUR
10m. It operates a large laboratory in Graauw, in the south of The
Netherlands, and the Altic agricultural laboratory in Dronten, in the north,
enabling nationwide coverage. LZV’s strong reputation in agricultural testing
is underpinned both by its breadth of service offering, and the quality of its
analyses. It has long standing relationships with the largest food growers and
producers, as well as environmental agencies in The Netherlands. Eurofins is
active in agricultural testing in the Nordic region, and in the UK; and LZV
provides the Group an opportunity to accelerate its roll-out of this
competence in continental Europe. The acquisition should also allow Eurofins
to expand its market share in agricultural testing by leveraging its increased
scale.

In addition, LZV has developed a solid position in pesticides and contaminants
testing in the domestic market. Given Eurofins’ strength in these activities,
LZV should be able to further develop these competencies by drawing on the
technical know-how and capabilities of the Group’s relevant competence centers
for these analyses.

Comment from Dr. Gilles Martin, Eurofins CEO: “LZV is an excellent geographic
and strategic fit with Eurofins’ existing activities in and around The
Netherlands. It expands our agricultural testing footprint in The Netherlands,
and allows us to leverage our strength in pesticides and contaminants testing
to further develop these activities in the country. We look forward to
strengthening LZV’s position in the market by offering the full range of
capabilities of the Group”.

For more information, please visit www.eurofins.com Notes for the editor:

Eurofins – a global leader in bio-analysis
Eurofins Scientific is the world leader in food and pharmaceutical products
testing. It is also number one in the world in the field of environmental
laboratory services and one of the global market leaders in agroscience,
genomics, discovery pharmacology and central laboratory services.

With over 13,000 staff in more than 170 laboratories across 34 countries,
Eurofins offers a portfolio of over 100,000 reliable analytical methods for
evaluating the safety, identity, composition, authenticity, origin and purity
of biological substances and products. The Group provides its customers with
high-quality services, accurate results in time and expert advice by its
highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding
both its technology portfolio and its geographic reach. Through R&D and
acquisitions, the Group draws on the latest developments in the field of
biotechnology and analytical chemistry to offer its clients unique analytical
solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in
its industry, Eurofins is ideally positioned to support its clients’
increasingly stringent quality and safety standards and the expanding demands
of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the NYSE Euronext Paris Stock
Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

Important disclaimer:

This press release contains forward-looking statements and estimates that
involve risks and uncertainties. The forward-looking statements and estimates
contained herein represent the judgement of Eurofins Scientific’ management as
of the date of this release. These forward-looking statements are not
guarantees for future performance, and the forward-looking events discussed in
this release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and estimates.
All statements and estimates are made based on the data available to the
Company as of the date of publication, but no guarantee can be made as to
their validity.

Contact:

Eurofins Investor Relations
Phone: +32-2-766 1620
E-mail: ir@eurofins.com